Ovarian cancer, the revised FIGO staging system, and the role of imaging

S Javadi, DM Ganeshan, A Qayyum… - American Journal of …, 2016 - Am Roentgen Ray Soc
OBJECTIVE. It is now recognized that ovarian cancer includes a heterogeneous group of
malignant epithelial tumors originating from the ovaries, fallopian tubes, or peritoneum. This …

[HTML][HTML] ESMO–ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours …

N Colombo, C Sessa, A du Bois, J Ledermann… - Annals of oncology, 2019 - Elsevier
The development of guidelines recommendations is one of the core activities of the
European Society for Medical Oncology (ESMO) and European Society of Gynaecologial …

Ovarian cancer, version 2.2020, NCCN clinical practice guidelines in oncology

DK Armstrong, RD Alvarez, JN Bakkum-Gamez… - Journal of the National …, 2021 - jnccn.org
Epithelial ovarian cancer is the leading cause of death from gynecologic cancer in the
United States and is the country's fifth most common cause of cancer mortality in women. A …

Staging classification for cancer of the ovary, fallopian tube, and peritoneum

J Prat… - International Journal of …, 2014 - Elsevier
Ovarian cancer is the seventh most common cancer diagnosis among women worldwide,
and the fifth most common cancer diagnosis among women in higher-resource regions [1] …

[BOOK][B] Perez & Brady's principles and practice of radiation oncology

EC Halperin, LW Brady, CA Perez, DE Wazer - 2013 - books.google.com
Inside the Sixth Edition of this now-classic reference, you will discover encyclopedic
coverage of topics ranging from basic science to sophisticated computer-based radiation …

Ovarian cancer

BT Hennessy, RL Coleman, M Markman - The lancet, 2009 - thelancet.com
The standard initial management of epithelial ovarian cancer consists of surgical staging,
operative tumour debulking including total abdominal hysterectomy and bilateral sal**o …

Prognostic factors for stage III epithelial ovarian cancer: a Gynecologic Oncology Group Study

WE Winter III, GL Maxwell, C Tian… - Journal of clinical …, 2007 - ascopubs.org
Purpose Conflicting results on prognostic factors for advanced epithelial ovarian cancer
(EOC) have been reported because of small sample size and heterogeneity of study …

Evaluating the risk of ovarian cancer before surgery using the ADNEX model to differentiate between benign, borderline, early and advanced stage invasive, and …

B Van Calster, K Van Hoorde, L Valentin, AC Testa… - Bmj, 2014 - bmj.com
Objectives To develop a risk prediction model to preoperatively discriminate between
benign, borderline, stage I invasive, stage II-IV invasive, and secondary metastatic ovarian …

Ovarian cancer, version 1.2016, NCCN clinical practice guidelines in oncology

RJ Morgan, DK Armstrong, RD Alvarez… - Journal of the National …, 2016 - jnccn.org
This selection from the NCCN Guidelines for Ovarian Cancer focuses on the less common
ovarian histopathologies (LCOHs), because new algorithms were added for LCOHs and …

Simple ultrasound rules to distinguish between benign and malignant adnexal masses before surgery: prospective validation by IOTA group

D Timmerman, L Ameye, D Fischerova, E Epstein… - Bmj, 2010 - bmj.com
Objectives To prospectively assess the diagnostic performance of simple ultrasound rules to
predict benignity/malignancy in an adnexal mass and to test the performance of the risk of …